CVRx | Barostim
Avatar

Baroreflex Activation Therapy: A Novel Approach for HFrEF Patients HFSA Symposium 2022 Discussion

By CVRx | Barostim FEATURING Marat Fudim, Robert Cole, Luanda Grazette
By CVRx | Barostim FEATURING Marat Fudim, Robert Cole, Luanda Grazette
120 views
November 16, 2022
Hear discussion and insights from Drs. Marat Fudim, Luanada Grazette, and Robert Cole following the HFSA 2022 symposium.
Comments 0
Login to view comments. Click here to Login

Featured Video

16:36
CVRx | Barostim

Beyond BeAT-HF - Real World Experience with Barostim

Feat. P. Patel

Recommended

12:12
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT in NYHA Class II…

Feat. W. Abraham
08:30
CVRx | Barostim

Real-World Experience with Baroreflex Activation Therapy: On-the-Job…

Feat. P. Mccann
07:22
CVRx | Barostim

Barostim in HFrEF Patients: International Strategies for Patient Sel…

Feat. J. Bauersachs, P. Wenzel, S. Anker, W. Abraham, P. Mccann
17:08
CVRx | Barostim

Integrating Barostim into a Comprehensive Heart Failure Program ISHL…

Feat. D. Yaranov, P. Patel, R. Gupta, J. Schmitto, E. Chung
16:36
CVRx | Barostim

Beyond BeAT-HF - Real World Experience with Barostim

Feat. P. Patel
11:08
CVRx | Barostim

Integrating Barostim into a Comprehensive Heart Failure Program

Feat. R. Gupta
16:18
CVRx | Barostim

ISHLT 2024: Integrating Barostim into a Comprehensive Heart Failure …

Feat. D. Yaranov
10:21
CVRx | Barostim

Patient Identification and Post-Implant Management within an Advance…

Feat. D. Yaranov
17:33
CVRx | Barostim

Beyond BeAT-HF: Real World Experience with Barostim

Feat. G. Panjrath
15:57
CVRx | Barostim

Long-Term Results of the BeAT-HF Clinical Study

Feat. J. Lindenfeld
13:58
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)

Feat. J. Thomas Heywood
11:18
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. G. Panjrath, D. Yaranov, J. Lindenfeld, J. Thomas Heywood
18:36
CVRx | Barostim

Barostim and the Window of Opportunity in Class II/III HFrEF Patient…

Feat. W. Abraham, G. Panjrath, D. Yaranov, P. Mccann
09:58
CVRx | Barostim

Barostim for HFrEF Patients

Feat. P. Mccann
10:18
CVRx | Barostim

New Insights from the BeAT-HF Clinical Study

Feat. W. Abraham
06:16
CVRx | Barostim

Challenges and Opportunities with Contemporary GDMT

Feat. D. Yaranov
12:16
CVRx | Barostim

HFSA 2023: Window of Opportunity – Who and When

Feat. G. Panjrath
16:32
CVRx | Barostim

ESC 2023: BeAT-HF: Long term outcome

Feat. M. Zile
11:49
CVRx | Barostim

ESC 2023: Unmet needs and opportunities with device therapies of HFr…

Feat. W. Abraham
11:43
CVRx | Barostim

ESC 2023: Real-world experience with Baroreflex Activation Therapy

Feat. F. Arribas
AUTOPLAY